Jamie Justice, Ph.D., is in the relatively new field of geroscience, which seeks to target biological aging processes to prevent or delay functional decline and age-related chronic diseases collectively, rather than one at a time. Her research training that spans disciplines, species, and intervention strategies. Current research includes: 1) efforts launch the clinical trial, Targeting Aging with MEtformin (TAME), which is designed to facilitate regulatory approval for the use of a drug for the purpose of slowing; 2) development of biomarkers of biological aging; 3) investigating the therapeutic potential of targeting the biologic aging hallmark cellular senescence in humans.